Presentations -
-
Shoji H, Heike Y, Tada K, Kitano S, Nishimura T, Shimada Y, Nagashima K, Ito A, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Yamada Y, Boku N, Hamaguchi T
The 18th ECCO - 40th ESMO European Cancer Congress,
2015.09,Poster presentation
-
Tada K, Shoji H, Kitano S, Nishimura T, Shimada Y, Nagashima K, Ito A, Honma Y, Iwasa S, Okita M, Takashima A, Kato K, Yamada Y, Katayama N, Boku N, Heike Y, Hamaguchi T
The 18th ECCO - 40th ESMO European Cancer Congress,
2015.09,Poster presentation
-
Association between the peripheral immune status of granulocytic myeloid-derived suppressor cells and progression-free survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy
H. Shoji, Y. Heike, K. Tada, S. Kitano, T. Nishimura, Y. Shimada, K. Nagashima, A. Ito, Y. Honma, S. Iwasa, N. Okita, A. Takashima, K. Kato, Y. Yamada, N. Boku, T. Hamaguchi
EUROPEAN JOURNAL OF CANCER,
2015.09,Oral presentation (general), ELSEVIER SCI LTD
-
Honma Y, Terauchi T, Tateishi U, Kano D, Nagashima K, Okita NT, Takashima A, Iwasa S, Kato K, Hamaguchi T, Shimada Y, Boku N, Yamada Y
2015 ASCO Annual Meeting,
2015.05,Poster presentation
-
A prospective study to evaluate the usefulness of the clanging tuning fork test and the nerve conduction velocity test for oxaliplatin-induced peripheral neuropathy
Hirashima Y, Hanaoka T, Watanabe K, Nagashima K, Inagaki T, Nishikawa K, Hisamatsu Y, Morinaga R, Otsu S, Kumamoto T, Shirao K
ASCO 2015 Gastrointestinal Cancers Symposium,
2015.01,Oral presentation (general)
-
Risks of severe adverse events of docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy of esophageal cancer
Yuda S, Kato K, Sasaki Y, Takahashi N, Shoji H, Takashima A, Okita NT, Honma Y, Iwasa S, Hamaguchi T, Yamada Y, Nagashima K, Boku N
ASCO 2015 Gastrointestinal Cancers Symposium,
2015.01,Oral presentation (general)
-
Asymptotic behaviors of the Mantel-Haenszel estimators under the common effect assumptions violated
Noma H, Nagashima K
Kyoto International Conference on Modern Statistics in the 21st Century,
2014.11,Oral presentation (general)
-
Serum epiregulin is associated with prognosis and skin toxicity on anti-EGFR antibody treatment in KRAS wild-type mCR
Kubo A, Yamada Y, Takahashi N, Nagashima K, Hashimoto H, Iwasa S, Honma Y, Okita N, Takashima A, Kato K, Hamaguchi T, Hayashi Y, Shimada Y
The 73rd Annual Meeting of the Japanese Cancer Association,
2014.09,Oral presentation (general)
-
KRAS野生型大腸癌患者における抗EGFR抗体投与に伴う臨床効果及び皮膚毒性に与える血清epiregulin濃度の影響(Serum epiregulin is associated with prognosis and skin toxicity on anti-EGFR antibody treatment in KRAS wild-type mCRC)
久保 晶子, 山田 康秀, 高橋 直樹, 長島 健悟, 橋本 浩伸, 岩佐 悟, 本間 義崇, 沖田 南都子, 高島 淳生, 加藤 健, 濱口 哲弥, 林 憲一, 島田 安博
日本癌学会総会記事,
2014.09,Oral presentation (general), 日本癌学会
-
高齢者切除不能の進行・再発胃癌を対象としたS-1/CDDP療法の多施設共同第Ⅱ相試験
岩佐悟, 濱口哲弥, 後藤昌弘, 岡崎俊介, 笹木有佑, 長井祐志, 浅見千佳, 長島健悟, 島田安博
第52回 日本癌治療学会学術集会,
2014.08,Oral presentation (general)
-
Comparison of the long-term toxicities with two different chemoradiotherapy for esophageal squamous cell carcinoma
Kubo E, Kato K, Honma Y, Iwasa S, Hamaguchi T, Yamada Y, Shimada Y, Ito Y, Itami J, Nagashima K
The 12th Annual Meeting of Japanese Society of Medical Oncology,
2014.07,Oral presentation (general)
-
Information criterion for Firth-type penalized partial likelihood in Cox regression
Nagashima K, Sato Y
The 27th International Biometric Conference,
2014.07,Oral presentation (general)
-
Serotype distribution and drug resistance of streptococcuspneumoniae isolated from children with community acquired pneumonia in Japan
Takahashi S, Ishiwada N, Hishiki H, Nagasawa K, Chang B, Nagashima K
13th International Congress on Pediatric Pulmonology,
2014.06,Oral presentation (general)
-
MULTICENTER PHASE II STUDY OF COMBINATION THERAPY WITH ORAL S-1 PLUS CISPLATIN IN ELDERLY PATIENTS WITH ADVANCED GASTRIC CANCER
Iwasa Satoru, Hamaguchi Tetsuya, Nagashima Kengo, Goto Masahiro, Okazaki Shunsuke, Sasaki Yusuke, Nagai Yushi, Asami Chika, Shimada Yasuhiro
ANNALS OF ONCOLOGY,
2014.06,Oral presentation (general), OXFORD UNIV PRESS
-
高齢者切除不能の進行・再発胃癌を対象としたS-1/CDDP療法の多施設共同第II相試験
岩佐 悟, 濱口 哲弥, 後藤 昌弘, 岡村 俊介, 笹木 有佑, 長井 祐志, 浅見 千佳, 長島 健悟, 島田 安博
日本癌治療学会誌,
2014.06,(一社)日本癌治療学会
-
Phase II study of neoadjuvant chemoradiotherapy with cisplatin plus 5-fluorouracil and elective nodal irradiation for stage II/III esophageal squamous cell carcinoma: A 2-year follow up
Kato K, Hashimoto J, Ito Y, Nagashima K, Kojima T, Daiko H, Akimoto T, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Igaki H
ASCO 2014 Gastrointestinal Cancers Symposium,
2014.01,Oral presentation (general)
-
進行・再発大腸がんのS-1/イリノテカン±ベバシズマブ療法 第II相試験の統合解析
山口達郎, 山田康秀, 岩佐悟, 松本寛, 市川靖史, 後藤歩, 安井久晃, 加藤健, 沖田南都子, 長島健悟, 島田安博
第51回 日本癌治療学会学術集会,
2013.10,Oral presentation (general)
-
高齢者切除不能進行・再発胃癌を対象としたS-1/CDDP療法の多施設共同第II相試験
岩佐悟, 濱口哲弥, 後藤昌弘, 富所隆, 笹木有佑, 長井祐志, 浅見千佳, 長島健悟, 島田安博
第51回 日本癌治療学会学術集会,
2013.10,Oral presentation (general)
-
Goto A, Yamada Y, Iwasa S, Nagashima K, Yamaguchi T, Ichikawa Y, Yasui H, Kato K, Okita NT, Shimada Y
The 17th ECCO, 38th ESMO, 32nd ESTRO, European Cancer Congress,
2013.09,Poster presentation
-
A prospective study to evaluate the usefulness of neurological test for oxaliplatin-induced peripheral neuropathy
Hirashima Y, Hanaoka T, Watanabe K, Nagashima K, Nishikawa K, Morinaga R, Otsu S, Kumamoto T, Shirao K
The 11th Annual Meeting of Japanese Society of Medical Oncology,
2013.08,Oral presentation (general)